Yuan Zhi
Stock Analyst at B. Riley Securities
(0.61)
# 3,731
Out of 4,829 analysts
22
Total ratings
40%
Success rate
-18.08%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIR Mirion Technologies | Maintains: Buy | $19 → $17 | $16.95 | +0.29% | 2 | Apr 16, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.5 → $1.2 | $0.73 | +64.38% | 1 | Mar 20, 2025 | |
| RADX Radiopharm Theranostics | Initiates: Buy | $15 | $4.06 | +269.46% | 1 | Mar 12, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $16 → $8 | $1.31 | +510.69% | 2 | Nov 11, 2024 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $3.50 | +414.29% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $7.16 | +109.50% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $0.89 | +237.08% | 1 | May 15, 2024 | |
| CATX Perspective Therapeutics | Maintains: Buy | $12 → $17 | $2.51 | +577.29% | 2 | Apr 9, 2024 | |
| AZTA Azenta | Maintains: Buy | $61 → $79 | $28.30 | +179.20% | 3 | Feb 1, 2024 | |
| ATNM Actinium Pharmaceuticals | Maintains: Buy | $20 → $16 | $1.55 | +932.26% | 4 | Dec 11, 2023 |
Mirion Technologies
Apr 16, 2025
Maintains: Buy
Price Target: $19 → $17
Current: $16.95
Upside: +0.29%
Hyperfine
Mar 20, 2025
Maintains: Buy
Price Target: $1.5 → $1.2
Current: $0.73
Upside: +64.38%
Radiopharm Theranostics
Mar 12, 2025
Initiates: Buy
Price Target: $15
Current: $4.06
Upside: +269.46%
Tango Therapeutics
Nov 11, 2024
Maintains: Buy
Price Target: $16 → $8
Current: $1.31
Upside: +510.69%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $3.50
Upside: +414.29%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $7.16
Upside: +109.50%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $0.89
Upside: +237.08%
Perspective Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $2.51
Upside: +577.29%
Azenta
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $28.30
Upside: +179.20%
Actinium Pharmaceuticals
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.55
Upside: +932.26%